{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-038045","form_type":"8-K","ticker":"FZMD","cik":"0000319016","company_name":"Fuse Medical, Inc.","filed_at":"2022-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.149387+00:00","generated_at":"2026-06-21T16:09:34.620855+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Fuse Medical Q3 net loss shrinks 99% to $9.4k; revenue up 7% to $4.5M","bullets":["Net revenues $4.5M (+7% YoY); gross profit $3M (67% margin vs 56% in prior year).","Net loss improved to $9,376 from $697,036 loss; loss reduced ~99% YoY.","Adjusted EBITDA positive $131,241 vs loss of $630,549 in Q3 2021, a 121% improvement.","Launched Fuse PSS Pedicle Screw System with minimally invasive options in Q3.","Expects continued growth from new product launches and direct sales force expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-038045","json":"https://secwatch.observer/filing/0001564590-22-038045.json","markdown":"https://secwatch.observer/filing/0001564590-22-038045.md","text":"https://secwatch.observer/filing/0001564590-22-038045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/319016/000156459022038045/0001564590-22-038045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/319016/000156459022038045/fzmd-8k_20221115.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T16:09:34.620855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a07fc1021da86f16cc68b49da0db25f3be9fd06a","claim":"Fuse Medical, Inc. reported third quarter ended September 30, 2022 results: revenue $4.5 million, net income net loss was $9,376.","evidence_excerpt":"Net revenues for the quarter ended September 30, 2022 were $4.5 million, compared to $4.2 million for the quarter ended September 30, 2021 which was an increase of approximately 7%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/319016/000156459022038045/0001564590-22-038045-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Revenue","value":"$4.5 million"},{"label":"Net income","value":"net loss was $9,376"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}